ArticleHemaSphere2023

Robust CRISPR-Cas9 Genetic Editing of Primary Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells.

Judith Mateos-Jaimez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.